About
Bing Lim is Chief Scientific Officer at Thymmune Therapeutics, an MD/PhD-trained physician-scientist with experience in drug discovery and cell therapy. He previously served as Senior Vice President for Cell Therapy at Sana Biotechnology and as Associate Vice President for discovery sciences at Merck, and spent 27 years as a principal investigator at Harvard Medical School and the Genome Institute of Singapore. His laboratory work included methods for pluripotent stem cell differentiation and transdifferentiation, molecular regulators of pluripotency, and markers and therapeutic targets of human tumor-initiating cells.
MD, PhD at Thymmune
Intro paths
→
In turn, Bing can intro founders to Thymmune's investors below.
Thymmune's investors · 2
Co-founders at Thymmune
SW
Stan WangMD, PhD
Experience
- Thymmune TherapeuticsChief Scientific Officercurrent2021 — presentCambridge, Massachusetts, United States
- Sana Biotechnology, Inc.Senior Vice President for Cell Therapy2019 — 2020
- MerckAssociate Vice President for Research Science and Translational Medicine2014 — 2019Singapore
- A*STAR - Agency for Science, Technology and ResearchSenior Group Leader (Stem Cell and Developmental Biology)2003 — 2018Singapore
- A*STAR - Agency for Science, Technology and ResearchAssociate Director (Cancer Stem Cell Biology)2011 — 2015Singapore
- Harvard Medical SchoolAssociate Professor of Medicine1993 — 2014
- Beth Israel Deaconess Medical CenterAssociate Physician1988 — 2014Greater Boston
Skills & more
ResearchStrategic AlliancesCross-functional CollaborationsGenomics1Pediatric Hematology/OncologyDrug DiscoveryTranslational ResearchEmbryonic Stem CellsCancer Stem CellsOncology1HematopoiesisFunctional Genomics
+1 more
Team ManagementFrom Bing's professional profile.
Frequently asked questions
- Who is Bing Lim?
- Bing Lim is Chief Scientific Officer at Thymmune Therapeutics, an MD/PhD-trained physician-scientist with experience in drug discovery and cell therapy. He previously served as Senior Vice President for Cell Therapy at Sana Biotechnology and as Associate Vice President for discovery sciences at Merck, and spent 27 years as a principal investigator at Harvard Medical School and the Genome Institute of Singapore. His laboratory work included methods for pluripotent stem cell differentiation and transdifferentiation, molecular regulators of pluripotency, and markers and therapeutic targets of human tumor-initiating cells.
- Where does Bing Lim work?
- Bing Lim is MD, PhD of Thymmune.
- What companies did Bing Lim found?
- Bing Lim founded Thymmune.
- Where did Bing Lim go to school?
- Bing Lim studied at University of Toronto (Doctor of Philosophy (PhD), Ph.D. in Cell and Molecular Biology); Harvard Medical School (Post-Doctoral Research Fellow, Retroviral Gene Therapy); University of Toronto (Fellow in Hematology / Oncology).
Founder mafias
University of Toronto mafia147
Also came through, then founded or led a company.
Ilya SutskeverBachelor's degreeFounded Safe Superintelligence +1Nick FrosstBachelor's of ScienceFounded CohereJeffrey KarpPhDFounded Tissium +3Shvet JainMAScFounded Panther +1Kiran GolluM.Sc.Founded Oodle +1Alex LevyFounded Atmo +1
+ 140 more
Harvard Medical School mafia49
Also came through, then founded or led a company.
Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Andrey ZarurClinical ImmunologyFounded Lumicell +2Lyle BerkowitzMedical informatics sub-fellowshipFounded Apollo Health +1Uday KumarDoctor of Medicine (MD)Founded Element Science +1Rami HannoushCIHR and NSERC Postdoctoral FellowFounded Epi BiologicsRushika FernandopulleM.D.Founded Iora Health
+ 42 more
Sana Biotechnology mafia4
Also came through, then founded or led a company.
Same school
Also attended University of Toronto431
Ilya SutskeverCo-founder of OpenAI; co-founder & CEO of Safe SuperintelligenceNick FrosstCo-founder of CohereYasmin RazaviInvestor at Spark CapitalImran BashirFounding Partner, Chief Operating Officer at Extreme Venture PartnersKarim GillaniGeneral Partner at Luge CapitalAndrew MiklasGeneral Partner at Y Combinator
+ 425 more
Also attended Harvard Medical School170
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 164 more
Shared employers
Also worked at Thymmune Therapeutics1
Also worked at Sana Biotechnology, Inc.4
Also worked at Merck130
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 124 more
Also worked at A*STAR - Agency for Science, Technology and Research37
Kelven LamInvestment Director - Water at Emerald Technology Ventures AgAnqi ChenInvestment Manager at QualgroDr Jeremy LimHealthcare Strategist at Verge HealthTech FundDr. Sidney YeeVenture Partner at iGlobe PartnersFong Ming KohPrincipal at LYFE CapitalJeremy LohCo-Founder and Managing Partner at Genesis Alternative Ventures
+ 31 more